Articles 

• 10-YEAR BIOCHEMICAL (PROSTATE-SPECIFIC ANTIGEN) CONTROL OF PROSTATE CANCER WITH 125 BRACHYTHERAPY
• Provider Volume and Outcomes Following Prostate Brachytherapy
• Comparison of 7- Year Outcomes Between LDR :Brachytherapy and High Dose IMRT for Patients With Clinically Localized Prostate Cancer
• Young Men have Equivalent Biochemical Outcomes Compared to Older Men After Treatment With Prostate Brachytherapy
• Patterns of Death Following Permanent Prostate Brachytherapy
• Prognostic Significance of the 5- Year PSA Value for Predicting Prostate Cancer Recurrence Following Brachytherapy
• The Influence of Age as a Predictor of Outcome in Prostate Cancer Patients Treated on RTOG Trials
• Comparsion of 7 Year Outcomes between LDR Brachytherapy & High Dose IMRT for Patients with Clinically Localized Prostate Cancer
• Patterns Of Death Following Permanent Prostate Brachytherapy
• Prognostic Significance of the 5 Year PSA Value For Predicting Prostate cancer Recurrence Following Brachytherapy
• The Influence of Age as as Predictor of Outcome in Prostate Cancer Patients Treated on RTOG Trials
• Young Man have Equivalent Biochemical Outcomes Compared to Older Men After Treatment with Prostate Brachytherapy
• Provider Volume and outcomes Following Prostate Brachytherapy
• Multicenter Analysis of Impact of High Biologically Effective Dose (BED) on Biochemical Failure(Phoenix Definition) and Survival Outcomes in Patients with Gleason Score 7-10 Prostate Cancer Treated by Permanent Prostate Brachytherapy
• 10-Year Biochemical (Prostate Specific Antigen) Control of Prostate Cancer with Brachytherapy
• Interval To Biochemical Failure Highly Prognostic For Distant Metastasis And Prostate Cancer-Specific Mortality After Radiotherapy
• Urinary dysfunction troubles men who undergo prostate removal